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Purpose: Regional lymph node (LN) metastases are detected in 57‒85% of patients with papillary thyroid carcinoma (PTC) 
and are associated with increased tumor recurrence. However, the management of lymphatic disease in patients with PTC 
has been ongoing source of debate. We have prospectively assessed the usefulness and accuracy of sentinel LN (SLN) biopsy 
for the detection of LN metastases in patients with PTC on preoperative imaging using single photon emission computed to-
mography/computed tomography (SPECT/CT) and 99mTc phytate. Methods: We prospectively assessed 39 patients with 
PTC who had risk factors for recurrence or with the necessity of intraoperative LN sampling for suspicious LN metastases on 
preoperative imaging from August 2010 to March 2011. The patients underwent preoperative lymphoscintigraphy and 
SPETC/CT and intraoperative SLN biopsy (SLNB). Results: 99mTc lymphoscintigraphy and SPECT/CT localized SLN in 38 
patients (97.4%), with the gamma probe identifying 2.15 mean SLNs in the lateral neck of the 39 patients. Skip metastasis was 
found in one patient, and lateral compartment LN metastasis in 17 (43.5%). The sensitivity, specificity, and accuracy of SLNB 
for lateral compartment LN metastasis were 88.2%, 100%, and 94.8%, respectively. SLNB was more accurate and useful for 
lateral than for central compartment LN metastasis. Conclusion: SPECT/CT improved SLN detection and anatomical local-
ization compared with lymphoscintigraphy. SLNB in patients with risk factors for recurrence or the necessity of intra-
operative LN sampling for suspected LN metastases on preoperative imaging was accurate in detecting LN metastases and 
may help in deciding whether to perform lateral compartment dissection in patients with PTC. 
Key Words: Papillary thyroid cancer, Sentinel lymph node biopsy, Single photon emission computed tomography, X-ray 
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INTRODUCTION
The incidence of thyroid cancer has increased con-
tinuously worldwide [1,2]. Papillary thyroid carcinoma 
(PTC) is the most common thyroid malignancy, account-
ing for up to 80% of primary thyroid cancers [3]. Cervical 
lymph node (LN) metastasis frequently occurs in patients 
with PTC, and up to 90% of patients with new thyroid ma-
lignancies are found to have LN metastases [4]. Since LN 
metastasis is a risk factor for recurrence [5]. The detection 
of such metastases prior to or during initial surgery may 
affect recurrence and patients survival. 
Although ultrasonography has been shown to be the 
most useful tool for preoperatively detecting cervical LN 
metastases, its accuracy has been found to vary widely, 
from 40% to 90%, and to be operator-dependent [6]. Use of 
a combinatioin of ultrasonography and a second method, 
such as intraoperative sentinel LN biopsy (SLNB), may 
identify LN metastases more [7-9]. 
SLNB is the gold standard for detecting LN metastases 
in patients with melanoma and breast cancer. This techni-
que has also been utilized in patients with thyroid cancer, 
using vital blue dye [10], or a radioisotope with favorable 
results observed in patients with PTC [11,12]. A comple-
mentary method, preoperative lymphoscintigraphy de-
fines the drainage basins and SLN locations of individual 
tumors [13].
However, because LN drainage in the head and neck is 
unpredictable and ambiguous, preoperative lympho-
scintigraphic SLN mapping is important for tailoring the 
surgical field in individual patients [14]. Since planar scin-
tigraphy did not provide the precise location of SLN, due 
to poor anatomic information, single photon emission 
computed tomography/computed tomography (SPECT/ 
CT) has been used to preoperatively map SLN in patients 
with head, neck and gynecologic cancer. We have, there-
fore, investigated the usefulness and accuracy of SLNB, as 
detected by preoperative SPECT/CT with technetium- 
99m phytate, of locoregional LN metastases in patients 
with PTC. To our knowledge, this is the first report on the 
use of SPECT/CT for localizing SLN in PTC. 
METHODS
Patients 
From July 2010 to March 2011, 39 patients with differ-
entiated PTC underwent SLNB of the central and lateral 
neck compartments in our institution. All patients had 
been preoperatively diagnosed with PTC by fine needle 
aspiration (FNA) biopsy and had risk factors for re-
currence or required intraoperative LN sampling for sus-
pected LN metastases on preoperative imaging. No pa-
tient had a history of either thyroid or neck surgery. 
Patients with other types of thyroid malignancies were 
excluded. The study was approved by the Institutional 
Review Board of our institution and written informed con-
sent was obtained from each patient. 
Scintigraphic technique 
Twenty MBq 99mTc phytate was injected into each tu-
mor, using a 26-gauge syringe. Early lymphoscintigraphy 
and SPECT/CT were performed 10 minutes later. Delayed 
lymphoscintigraphy and SPECT/CT were performed, 2 
hours after injection. Surgery was performed 2 to 4 hours 
after injection. Anterior planar images were obtained dur-
ing lymphoscintigraphy. SPECT/CT emission/transmis-
sion was performed using a hybrid system consisting of a 
dual-head gamma camera with a low-dose X-ray tube in-
stalled in its gantry (Infinia Hawkeye 4 SPECT-CT, GE 
Healthcare, Waukesha, WI, USA). This system allows both 
transmission and emission acquisitions without changing 
the patient’s position. SPECT acquisition parameters for 
SLN detection included a matrix size of 128 × 128, 180 de-
gree in anterior L-moderotation, and a 4 degree angle step 
with 25s time frame. Transmission data of the patient were 
corrected and reconstructed using the filtered back-
projection to produce cross-sectional attenuation of the 
imaged tissue. The SPECT and CT images were fused on 
the Xeleris Function Imaging Workstation version 2.1507. 
The hottest node found positive on both preoperative lym-
phoscintigraphy and SPECT/CT was considered the senti-
nel LN, as previously reported [15]. 
SLN identification at surgery
Under general anesthesia, a standard, transverse, low- 
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Variable Value
Age (yr) 45.7 (30–70)
Sex (M/F) 9/30
Extent of thyroidectomy
    Lobectomy 1 (2.6)
    Total thyroidectomy 38 (97.4)
Sentinel lymph node
    No. of lateral SLN     4.73 ± 3.063 (0–12)
    No. of level of SLN   2.15 ± 0.921 (0–4)
    No. of SLN per level     2.22 ± 1.36 (0–6)
No. of retrieved lymph nodes
    Total   31.33 ± 13.33 (9–68)
    Central compartment     12.56 ± 6.43 (2–29)
    Lateral neck   18.76 ± 12.41 (7–48)
Extent of lymph node metastasis
    Central compartment 29 (74.3)
    Unilateral neck 13 (33.3)
    Bilateral neck   4 (10.2)
Tumor size (cm) 1.30 ± 0.74 (0.2–3.5)
Multiplicity 17 (43.5)
Extrathyroidal extension 30 (76.9)
No. of with lymph node metastases 29 (74.3)
BRAF mutation 22 (56.4)
Transient hypoparathyroidism 13/32 (40.6)
Permanent hypoparathyroidism   1/32 (3.1)
Vocal cord palsy   1/39 (2.5)
Chyle leakage   1/39 (2.5)
Values are presented as mean (range), number (%), or mean ±
standard deviation (range).
SLN, sentinel lymph node.
Table 1. Clinicopathologic features of the patients cohort
Results Total No. of patients (%)
Sensitivity 17  15 (88.2)
Specificity 22 22 (100)
Accuracy 39 37 (94.8)
Positive predictive value 15 15 (100)
Negative predictive value 24 22 (91.6)
Table 2. The accuracy of lateral neck lymph node metastasis
Results Total No. of patients (%)
Sensitivity 24  10 (79.1)
Specificity 10 10 (100)
Accuracy 34 29 (85.2)
Positive predictive value 19 19 (100)
Negative predictive value 15 10 (66.6)
Table 3. The accuracy of central neck lymph node metastasis
collar skin incision was made, and the myocutaneous flap 
was lifted. A fascial incision was made between the strap 
musculature and the sternocleidomastoid muscle, expos-
ing the ipsilateral jugular vein. The SLN was harvested us-
ing the intraoperative hand-held probe (Neoprobe 2000, 
Johnson & Johnson Medical, Hamburg, Germany) and 
sent for both frozen and permanent sections. Total thyroi-
dectomy was completed subsequently and all LNs of the 
central compartment were dissected. Modified radical 
neck dissection (mRND) was performed only in patients 
with positive LNs, and the nodes were labeled and sent for 
permanent histological section. All patients underwent 
compartment dissection at cervical levels II, III and IV. 
The radioactivity counts of the lymphatic basin were as-
sessed before and after excision of each node, and the ra-
dioactivity of each excised node was recorded after 
excision. Any node that had a count of at least 10% of the 
radioactivity of the hottest node was excised. 
Data analysis
Pathologic specimens were stained with hematoxylin 
and eosin and were observed under light microscopy. The 
sensitivity, specificity, accuracy, and positive predictive 
value (PPV) and negative predictive value (NPV) of SLN 
biopsies, were calculated. Other variables were inves-
tigated using t-test and chi-square tests. All statistical cal-
culations were performed using SPSS ver. 13.0 (SPSS Inc., 
Chicago, IL, USA). Postsurgical morbidity information 
was obtained from follow-up clinical and laboratory data. 
RESULTS
We assessed 39 patients (9 males and 30 females), of 
mean age 45 years (range, 30 to 70 years). Mean (±standard 
deviation) tumor size was 1.30 ± 0.73 cm. Bilateral jugular 
LN metastases were found in 4 patients, and unilateral 
jugular LN metastases in 13. The demographic and clinical 
characteristics of these patients, as well as their treatments 
and morbidities, are summarized in Table 1. 
A SLN was detected in 38 patients (97.4%). The mean 
number of SLNs per patients was 4.73 ± 3.06 (range, 0 to 
12), the mean number of lateral compartments, in which 
SLN was detected, was 2.15 ± 0.921 (range, 0 to 4), and the 
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Fig. 1. Frequency of tumor sites and metastatic lymph node 
distribution (P = 0.055). 1, upper; 2, middle and lower.
mean number of SLNs per lateral compartment was 2.22 ± 
1.36 (range, 0 to 6). The sensitivity, specificity, accuracy, 
PPV and NPV of SLNB for lateral LN metastasis were 
88.2%, 100%, 94.8%, 100%, and 91.6%, respectively (Table 
2). The sensitivity, accuracy and NPV for lateral LN meta-
stasis were higher than those for central LN metastasis 
(Table 3). 
The association between the tumor sites and the pattern 
of LN metastasis in the ipsilateral compartment was not 
statistically significant (P = 0.055) (Fig. 1). In the patient 
with the skip metastasis, the primary tumor was located in 
the upper portion of the thyroid gland. 
When we calculated the concordance rate based on cer-
vical levels between suspicious LNs on US and SPECT/CT, 
the mean concordance rate was 27.9%. 
When we compared preoperative US-guided FNA with 
intraoperative SLNB in 11 patients, the sensitivity of SLNB 
was higher than that of preoperative FNA at lateral neck 
(88.2% vs. 33.3%) and central LN metastases in 7 patients 
among them were diagnosed with SLNB only. 
DISCUSSION 
PTC is a representative histological type of thyroid 
cancer. It shows a mild behavior and has an excellent 
prognosis. However, LN metastases are frequently de-
tected, primarily in cervical LN. Cervical LN metastases 
have been associated with a higher incidence of recurrence 
[16,17]. Although radioiodine treatment may reduce re-
currence, 131I ablation was effective in only 10% of 
high-risk patients according to the AMES (age, metastasis 
to distant sites, extrathyroidal invasion, size) classifica-
tion, and was not effective in 30% of low-risk patients [18]. 
Ultrasonography is useful in the preoperative assess-
ment of cervical LN metastasis in patients with PTC [6]. 
However, a diagnosis of LN metastasis is difficult, because 
most patients with PTC have multiple, very small nodes 
＜5 mm in diameter and metastatic LNs may show no 
change on serial imaging over several years [3]. Therefore 
the accuracy of ultrasonography in detecting cervical LN 
metastasis is not very high. The accuracy of loss of fatty hi-
lum, round shape, calcification, cystic change or abnormal 
vascularity has been reported to range from 51% to 77% 
[19]. Ultrasonography may be complemented by measur-
ing Tg in FNA (FNA-Tg) or by LN sampling during sur-
gery. However, false positive or false negative FNA-Tg re-
sults have been reported, although their frequencies were 
low, and FNA-Tg cannot be performed in patients with ob-
struction of the carotid artery [20]. Moreover, it may be im-
possible to dissect LNs targeted during intraoperative 
sampling, because of the necessity to perform blunt dis-
section without anatomic landmarks. Therefore, in these 
patients, SLNB may accurately diagnose LN metastases. 
To date, indication for SLNB have not been established. 
The recurrence rate in cervical LNs has been reported to 
range from 5.8% to 10.7% [6,21,22], with risk factors for re-
currence including age, tumor size, extrathyroidal ex-
tension, LN metastasis and sex, et al. [6,21]. For example, 
recurrence rates were reported to be higher in patients 
＜30 years of age and patients with larger sized tumors, 
cervical LN metastasis, local invasion [21]. Another study 
reported that risk factors for recurrence were age ＞54 
years, LN metastasis and tumor size ＞4 cm [6]. 
Prophylactic mRND has been recommended to prevent 
recurrence in cervical LNs [6,23]. For example, patients 
with LN metastasis or, capsular invasion and woman ＞60 
years of age were reported to benefit from mRND [23]. 
Similarly, prophylactic mRND may be beneficial in pa-
tients with two or more of the following characteristics: 
male gender, age ≥55 years, maximal tumor diameter ＞3 
cm, and massive extrahyroid extension of the tumor [6]. 
Due to the high morbidity rates associated with mRND, 
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Fig. 2. Single photon emission com-
puted tomography/computed tomo-
graphy of the basin from the right 
jugular lymph node (LN) of cervical 
level II to the right retropharyngeal 
LN.
however, the gold standard of lateral LN management is 
not prophylactic, but therapeutic mRND. 
Therefore selective SLNB may determine whether ther-
apeutic mRND should be utilized in patients ＜30 or ＞54 
years of age, with tumor size ＞3 cm in diameter, or with 
local invasioin, or to reduce false positive or false negative 
FNA cytology or FNA-Tg results.
We assessed the usefulness and accuracy of SLNB in pa-
tients with risk factors for recurrence or requiring intra-
operative LN sampling for suspected LN metastases on 
preoperative SPECT/CT. We found that the sensitivity, 
specificity, accuracy, and PPV of SLNB for lateral and cen-
tral LN metastases were comparable to results from pre-
vious reports that did not utilize SPECT/CT, with sensi-
tivity ranged from 77.7% to 91% and accuracies from 90% 
to 95.3% [24,25]. In addition, the high resolution and ana-
tomic information of SLN provided by SPECT/CT made 
intraoperative gamma probing easier, compared with in-
formation provided by palpation and inspection [15]. 
In addition, SPECT/CT may also show pathway of 
lymph basins. We observed one patients with a lymph ba-
sin extending from the right jugular LN at cervical level II 
to the right retropharyngeal LN (Fig. 2), and another with 
a basin extending from the right paratracheal  to the right 
high mediastinal LN (Fig. 3). However, the distribution of 
SLNs was not similar to that of metastatic LNs in the later-
al neck. The ipsilateral distribution of SLNs showed the 
highest frequency at level IV, whereas the distribution of 
metastatic LNs showed the highest frequency at level III. 
Generally, lymphatic metastasis from differentiated 
PTC occurs in a stepwise manner from the LNs in the tra-
cheoesophageal groove to the LNs in the jugular chain, in-
cluding the supraclavicular fossa [26]. Following the ini-
tial metastases in the central compartment, LN metastases 
were observed in the deep inferior and lateral cervical no-
des, with no relation with tumor location [27]. We also 
found that the pattern of LN metastasis is not related to the 
primary tumor site. However, a skip metastasis, defined as 
lateral without central LN metastasis and observed in 
7.7% to 15.3% of patients [28-30], was observed in only one 
patients with PTC in the upper portion of thyroid gland. 
Therefore, the relationship between tumor location and 
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Fig. 3. Single photon emission com-
puted tomography/computed tomo-
graphy of the basin from the right 
paratracheal lymph node (LN) to the 
right high mediastinal LN.
the pattern of LN metastasis requires further inves-
tigation.
Although SLNB is useful to identify the LN metastasis, 
it has two demerits. Unnecessary lateral LN dissection can 
be performed in spite of subclinical LN metastases, which 
are not related with recurrence, because the frequency of 
occult LN metastases of papillary thyroid cancer is 40% to 
90% [10]. In addition, SLNB takes long surgical time be-
cause two or more SLN are identified in most of our pa-
tients (Table 1) dut to the rich lymphatic system of the thy-
roid gland. Therefore, routine SLNB may result in longer 
surgical time and hospitalization with increased surgical 
morbidity.
In conclusion, SLNB using SPECT/CT with techneti-
num-99m may be useful in accurately assessing LN stage 
during surgery patients with risk factors for recurrence or 
those requiring intraoperative LN sampling for suspected 
LN metastases on preoperative imaging. However, fur-
ther studies are required for appropriate method of SLNB, 
by which the distribution of SLNs can be closer to those of 
metastatic LNs for the sake of avoiding unnecessary dis-
section in 67% of the patients without LN metastasis.
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